Nanobiotix ADRs Jump Over 50% After Agreement With J&J’s Janssen Pharmaceutical – Investopedia July 10, 2023
J&J capitalizes on Nanobiotix cash crunch to capture late-phase cancer candidate for $30M upfront – FierceBiotech July 10, 2023